ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Generic Paclitaxel Approval Withstands Court Challenge.

May 4, 2001

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

NCI Evaluating PDQ Evaluation

September 1, 1989

New Year Sees Growing Attacks On Cancer Program; Critics Repeat Untrue Charges, OMB Continues

January 3, 1975

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

Obey Convinces House Hew Subcommittee to Cut $17 Million Control, Give It To Bioassays

June 1, 1979